Literature DB >> 17017667

Photodynamic therapy in early lung cancer: a report of two cases.

Tae Won Jang1, Hee Kyoo Kim, Chul Ho Oak, Mann Hong Jung.   

Abstract

Photodynamic therapy (PDT) that is based on the science of photochemistry has been recognized as a lung sparing local therapeutic modality that can achieve remarkable responses. It is an alternative treatment for early stage lung cancer patients who have poor lung function or multiple sites of cancer. Recently we treated a 70-year-old man who presented with squamous carcinoma in situ at a previous pneumonectomy site, and a 64-year-old man with a newly developed secondary superficial lung cancer, with PDT. There were no complications related to the procedure. Both patients had poor lung function due to prior lung cancer surgery. Clinical and histological complete remissions were achieved without any evidence of recurrence during 30 months of follow-up in both patients.

Entities:  

Mesh:

Year:  2006        PMID: 17017667      PMCID: PMC3890721          DOI: 10.3904/kjim.2006.21.3.178

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  13 in total

1.  The use of a derivative of hematoporhyrin in tumor detection.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  J Natl Cancer Inst       Date:  1961-01       Impact factor: 13.506

2.  Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study.

Authors:  M Pérol; R Caliandro; P Pommier; C Malet; X Montbarbon; C Carrie; J M Ardiet
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

3.  Photodynamic therapy for early stage squamous cell carcinoma of the lung.

Authors:  D A Cortese; E S Edell; J H Kinsey
Journal:  Mayo Clin Proc       Date:  1997-07       Impact factor: 7.616

4.  Photodynamic therapy (PDT) for lung cancer: the Yorkshire Laser Centre experience.

Authors:  K Moghissi; Kate Dixon; J A C Thorpe; C Oxtoby; M R Stringer
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-11       Impact factor: 3.631

5.  Photodynamic therapy (PDT) of lung cancer: experience of the Tokyo Medical University.

Authors:  Harubumi Kato; Masahiko Harada; Shu Ichinose; Jitsuo Usuda; Takaaki Tsuchida; Tetsuya Okunaka
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-05       Impact factor: 3.631

6.  The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases.

Authors:  K Moghissi; K Dixon; M Stringer; T Freeman; A Thorpe; S Brown
Journal:  Eur J Cardiothorac Surg       Date:  1999-01       Impact factor: 4.191

Review 7.  Bronchoscopic, photodynamic, and laser diagnosis and therapy of lung neoplasms.

Authors:  S Lam
Journal:  Curr Opin Pulm Med       Date:  1996-07       Impact factor: 3.155

8.  Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer.

Authors:  S Imamura; Y Kusunoki; N Takifuji; S Kudo; K Matsui; N Masuda; M Takada; S Negoro; S Ryu; M Fukuoka
Journal:  Cancer       Date:  1994-03-15       Impact factor: 6.860

9.  Photoradiation therapy for the treatment of malignant tumors.

Authors:  T J Dougherty; J E Kaufman; A Goldfarb; K R Weishaupt; D Boyle; A Mittleman
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

10.  Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer.

Authors:  Y Hayata; H Kato; C Konaka; J Ono; N Takizawa
Journal:  Chest       Date:  1982-03       Impact factor: 9.410

View more
  3 in total

Review 1.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

Review 2.  Endoscopic cryotherapy of lung and bronchial tumors: a systematic review.

Authors:  Seon-Heui Lee; Won-Jung Choi; Sook-Whan Sung; Young-Kyoon Kim; Chi-Hong Kim; Jae-Il Zo; Kwang-Joo Park
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 3.165

3.  Repurposing Tranexamic Acid as an Anticancer Agent.

Authors:  Mary E Law; Bradley J Davis; Amanda F Ghilardi; Elham Yaaghubi; Zaafir M Dulloo; Mengxiong Wang; Olga A Guryanova; Coy D Heldermon; Stephan C Jahn; Ronald K Castellano; Brian K Law
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.